Eiger BioPharmaceuticals, Inc. (EIGR): Price and Financial Metrics

EIGR POWR Grades

• Value is the dimension where EIGR ranks best; there it ranks ahead of 63.71% of US stocks.
• The strongest trend for EIGR is in Sentiment, which has been heading up over the past 179 days.
• EIGR's current lowest rank is in the Quality metric (where it is better than 5.21% of US stocks).

EIGR Stock Summary

• Of note is the ratio of Eiger BioPharmaceuticals Inc's sales and general administrative expense to its total operating expenses; merely 12% of US stocks have a lower such ratio.
• EIGR's price/sales ratio is 26.99; that's higher than the P/S ratio of 94.29% of US stocks.
• Revenue growth over the past 12 months for Eiger BioPharmaceuticals Inc comes in at 111.42%, a number that bests 92.65% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to Eiger BioPharmaceuticals Inc, a group of peers worth examining would be SQZ, MEIP, GLYC, CTMX, and WVE.
• Visit EIGR's SEC page to see the company's official filings. To visit the company's web site, go to www.eigerbio.com.

EIGR Valuation Summary

• EIGR's price/sales ratio is 48.1; this is 323.79% higher than that of the median Healthcare stock.
• Over the past 92 months, EIGR's price/sales ratio has gone NA NA.
• EIGR's EV/EBIT ratio has moved down 5.1 over the prior 92 months.

Below are key valuation metrics over time for EIGR.

EIGR Growth Metrics

The 5 year net income to common stockholders growth rate now stands at -82.55%.
• Its 2 year cash and equivalents growth rate is now at -31.94%.
• Its 3 year net cashflow from operations growth rate is now at -76.37%.

Over the past 34 months, EIGR's revenue has gone up $12,142,000.

The table below shows EIGR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	12.142	-71.342	-33.917
2021-09-30	8.782	-70.092	-30.955
2021-06-30	5.743	-64.94	-24.412
2021-03-31	3.646	-60.378	-20.564
2020-12-31	0	-63.185	-65.051
2020-09-30	0	-62.641	-63.165

EIGR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• EIGR has a Quality Grade of F, ranking ahead of 1.43% of graded US stocks.
• EIGR's asset turnover comes in at 0.037 -- ranking 341st of 682 Pharmaceutical Products stocks.
• ATNM, MNOV, and ATRA are the stocks whose asset turnover ratios are most correlated with EIGR.

The table below shows EIGR's key quality metrics over time.